Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment

• Status: Completed
• Trial end date: 2012-12-01

Summary

This study aims to evaluate the safety and effect of interferon-alpha lozenges when used in combination with oseltamivir (Tamiflu) to treat influenza.

• Phase: Phase 2

Details

• Lead Sponsor: Amarillo Biosciences, Inc.
• Collaborator: CytoPharm, Inc.
• Treatments: Interferon-alpha; Interferons; Oseltamivir